UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Review of human papillomavirus (HPV) burden and HPV vaccination for gay, bisexual, and other men who have sex with men and transgender women in the United States

Human vaccines & immunotherapeutics, 2022-12, Vol.18 (1), p.2016007-2016007

2022

Volltextzugriff (PDF)

CCR5 Antagonism in HIV Infection: Current Concepts and Future Opportunities

Annual review of medicine, 2012-01, Vol.63 (1), p.81-93

2012

Volltextzugriff (PDF)

Phase 2 Study of the Safety and Efficacy of Vicriviroc, a CCR5 Inhibitor, in HIV-1-Infected, Treatment-Experienced Patients: AIDS Clinical Trials Group 5211

The Journal of infectious diseases, 2007-07, Vol.196 (2), p.304-312

2007

Volltextzugriff (PDF)

No change in health-related quality of life for at-risk U.S. women and men starting HIV pre-exposure prophylaxis (PrEP): Findings from HPTN 069/ACTG A5305

PloS one, 2018-12, Vol.13 (12), p.e0206577-e0206577

2018

Volltextzugriff (PDF)

HIV Type 1 Chemokine Coreceptor Use among Antiretroviral-Experienced Patients Screened for a Clinical Trial of a CCR5 Inhibitor: AIDS Clinical Trial Group A5211

Clinical infectious diseases, 2007-02, Vol.44 (4), p.591-595

2007

Volltextzugriff (PDF)

HIV-1-Specific Antibody Response and Function after DNA Prime and Recombinant Adenovirus 5 Boost HIV Vaccine in HIV-Infected Subjects

PloS one, 2016-08, Vol.11 (8), p.e0160341-e0160341

2016

Volltextzugriff (PDF)

A Randomized, Placebo-Controlled Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Adults Aged 27 Years or Older: AIDS Clinical Trials Group Protocol A5298

Clinical infectious diseases, 2018-10, Vol.67 (9), p.1339-1346

2018

Volltextzugriff (PDF)

Response to Vicriviroc in Treatment-Experienced Subjects, as Determined by an Enhanced-Sensitivity Coreceptor Tropism Assay: Reanalysis of AIDS Clinical Trials Group A5211

The Journal of infectious diseases, 2009-12, Vol.200 (11), p.1724-1728

2009

Volltextzugriff (PDF)

Another Call for Widespread Human Papillomavirus Vaccination

The Journal of infectious diseases, 2020-06, Vol.222 (2), p.171-172

2020

Volltextzugriff (PDF)

Development and Pilot of an Mpox Severity Scoring System

The Journal of infectious diseases, 2024-03, Vol.229 (Supplement_2), p.S229-S233

2024

Volltextzugriff (PDF)

Regimen Simplification to Atazanavir-Ritonavir Alone as Maintenance Antiretroviral Therapy: Final 48-Week Clinical and Virologic Outcomes

The Journal of infectious diseases, 2009-03, Vol.199 (6), p.866-871

2009

Volltextzugriff (PDF)

Human papillomavirus-related malignancies in HIV infection: anal and oropharyngeal cancers

Topics in antiviral medicine, 2018-09, Vol.26 (3), p.85-88

Wilkin, Timothy J

2018

Volltextzugriff (PDF)

Baseline natural killer and T cell populations correlation with virologic outcome after regimen simplification to atazanavir/ritonavir alone (ACTG 5201)

PloS one, 2014-05, Vol.9 (5), p.e95524-e95524

2014

Volltextzugriff (PDF)

Effect of therapeutic intensification followed by HIV DNA prime and rAd5 boost vaccination on HIV-specific immunity and HIV reservoir (EraMune 02): a multicentre randomised clinical trial

The lancet HIV, 2015-03, Vol.2 (3), p.e82-e91

2015

Volltextzugriff (PDF)

The Association between Smoking and Anal Human Papillomavirus in the HPV Infection in Men Study

Cancer epidemiology, biomarkers & prevention, 2022-08, Vol.31 (8), p.1546-1553

2022

Volltextzugriff (PDF)

Expectations of preventative benefits and risk behaviors in a randomized trial evaluating oral HIV preexposure prophylaxis candidates

AIDS care, 2024-08, Vol.36 (8), p.1172-1178

2024

Volltextzugriff (PDF)

Oral and systemic HPV antibody kinetics post-vaccination among HIV-positive and HIV-negative men

Vaccine, 2019-04, Vol.37 (18), p.2502-2510

2019

Volltextzugriff (PDF)

SARS CoV-2 mRNA vaccination exposes latent HIV to Nef-specific CD8 + T-cells

Nature communications, 2022-08, Vol.13 (1), p.4888-15, Article 4888

2022

Volltextzugriff (PDF)

Bone changes with candidate PrEP regimens containing tenofovir disoproxil fumarate and/or maraviroc and/or emtricitabine in US men and women: HPTN 069/ACTG A5305

Journal of antimicrobial chemotherapy, 2022-02, Vol.77 (2), p.500-506

2022

Volltextzugriff (PDF)

CROI 2023: Advances in Antiviral Therapy in HIV and Viral Hepatitis

Topics in antiviral medicine, 2023-05, Vol.31 (3), p.445-467

2023

Volltextzugriff (PDF)

An Updated Systematic Review of Human Papillomavirus Genotype Distribution by Cervical Disease Grade in Women Living With Human Immunodeficiency Virus Highlights Limited Findings From Latin America

Sexually transmitted diseases, 2021-12, Vol.48 (12), p.e248-e254

2021

Volltextzugriff (PDF)

Higher colorectal tissue HIV infectivity in cisgender women compared with MSM before and during oral preexposure prophylaxis

AIDS (London), 2021-08, Vol.35 (10), p.1585-1595

2021

Volltextzugriff (PDF)

Design of the ANal Cancer/HSIL Outcomes Research study (ANCHOR study): A randomized study to prevent anal cancer among persons living with HIV

Contemporary clinical trials, 2022-02, Vol.113, p.106679-106679, Article 106679

2022

Volltextzugriff (PDF)

CROI 2022: advances in antiviral therapy for HIV, COVID-19, and viral hepatitis

Topics in antiviral medicine, 2022-06, Vol.30 (3), p.490-521

2022

Volltextzugriff (PDF)

1 – 25 von 149

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(118)
Mit Volltextzugriff
(119)

Publikationsform

Sprache

Englisch
(149)

Erscheinungsjahr

n.n

Thema

Humans
(106)
Science & Technology
(99)
Life Sciences & Biomedicine
(91)
Female
(62)
Male
(62)
Hiv
(56)
Infectious Diseases
(56)
Adult
(53)
Middle Aged
(49)
Immunology
(42)
Hiv Infections - Drug Therapy
(36)
Human Immunodeficiency Virus
(34)
Microbiology
(25)
Aids
(24)
Biological And Medical Sciences
(24)
Medical Sciences
(24)
Clinical Trials
(22)
Treatment Outcome
(22)
Anti-Retroviral Agents - Therapeutic Use
(21)
Virology
(20)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Review of human papillomavirus (HPV) burden and HPV vaccination for gay, bisexual, and other men who have sex with men and transgender women in the United States

CCR5 Antagonism in HIV Infection: Current Concepts and Future Opportunities

Phase 2 Study of the Safety and Efficacy of Vicriviroc, a CCR5 Inhibitor, in HIV-1-Infected, Treatment-Experienced Patients: AIDS Clinical Trials Group 5211

No change in health-related quality of life for at-risk U.S. women and men starting HIV pre-exposure prophylaxis (PrEP): Findings from HPTN 069/ACTG A5305

HIV Type 1 Chemokine Coreceptor Use among Antiretroviral-Experienced Patients Screened for a Clinical Trial of a CCR5 Inhibitor: AIDS Clinical Trial Group A5211

Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer

HIV-1-Specific Antibody Response and Function after DNA Prime and Recombinant Adenovirus 5 Boost HIV Vaccine in HIV-Infected Subjects

A Randomized, Placebo-Controlled Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Adults Aged 27 Years or Older: AIDS Clinical Trials Group Protocol A5298

Response to Vicriviroc in Treatment-Experienced Subjects, as Determined by an Enhanced-Sensitivity Coreceptor Tropism Assay: Reanalysis of AIDS Clinical Trials Group A5211

Another Call for Widespread Human Papillomavirus Vaccination

Development and Pilot of an Mpox Severity Scoring System

Regimen Simplification to Atazanavir-Ritonavir Alone as Maintenance Antiretroviral Therapy: Final 48-Week Clinical and Virologic Outcomes

Human papillomavirus-related malignancies in HIV infection: anal and oropharyngeal cancers

Baseline natural killer and T cell populations correlation with virologic outcome after regimen simplification to atazanavir/ritonavir alone (ACTG 5201)

Effect of therapeutic intensification followed by HIV DNA prime and rAd5 boost vaccination on HIV-specific immunity and HIV reservoir (EraMune 02): a multicentre randomised clinical trial

The Association between Smoking and Anal Human Papillomavirus in the HPV Infection in Men Study

Expectations of preventative benefits and risk behaviors in a randomized trial evaluating oral HIV preexposure prophylaxis candidates

Oral and systemic HPV antibody kinetics post-vaccination among HIV-positive and HIV-negative men

SARS CoV-2 mRNA vaccination exposes latent HIV to Nef-specific CD8 + T-cells

Bone changes with candidate PrEP regimens containing tenofovir disoproxil fumarate and/or maraviroc and/or emtricitabine in US men and women: HPTN 069/ACTG A5305

CROI 2023: Advances in Antiviral Therapy in HIV and Viral Hepatitis

An Updated Systematic Review of Human Papillomavirus Genotype Distribution by Cervical Disease Grade in Women Living With Human Immunodeficiency Virus Highlights Limited Findings From Latin America

Higher colorectal tissue HIV infectivity in cisgender women compared with MSM before and during oral preexposure prophylaxis

Design of the ANal Cancer/HSIL Outcomes Research study (ANCHOR study): A randomized study to prevent anal cancer among persons living with HIV

CROI 2022: advances in antiviral therapy for HIV, COVID-19, and viral hepatitis

Suchergebnisse filtern